Effects of Isotretinoin on Smell

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorUşak University

About this trial

Isotretinoin is a common medicine used to treat moderate to severe acne. It often causes dryness of the skin and the inside of the nose. Because a normal sense of smell depends on a healthy nasal lining, this dryness may affect how well a person can smell.

This study will examine whether isotretinoin treatment changes the sense of smell in adults with acne. Before starting isotretinoin, participants will complete a standardized smell test and two short questionnaires about nasal symptoms and quality of life: the Nasal Obstruction Symptom Evaluation (NOSE) scale and the 22-item Sino-Nasal Outcome Test (SNOT-22). After at least 4 weeks of treatment, the same smell test and questionnaires will be repeated.

By comparing results before and after treatment, the study will test the hypothesis that isotretinoin has a negative effect on olfactory function and may reduce patients' ability to smell.

Eligibility criteria

Qualifiers

Diagnosed with acne and scheduled to start oral isotretinoin as part of routine dermatology care

Willing to participate and able to give informed consent

Not currently smoking

No history of allergic rhinitis, sinusitis, or active upper respiratory infection

Disqualifiers

Younger than 18 years or older than 45 years

Current cigarette smoking

History of chronic sinonasal disease

Any condition that would prevent completing the smell test

Trial design

Treatments tested in this trial

  • isotretinoin

Treatment groups

54 Participants
are divided into 1 treatment group

Sponsors and collaborators

Uşak University

Lead sponsor

The Scientific and Technological Research Council of Turkey

Collaborator